Transferrin-Conjugated Docetaxel-PLGA Nanoparticles for Tumor Targeting: Influence on MCF-7 Cell Cycle.
PLGA nanoparticles
docetaxel trihydrate
factorial design
transferrin conjugate
tumor targeting
Journal
Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357
Informations de publication
Date de publication:
19 Nov 2019
19 Nov 2019
Historique:
received:
18
10
2019
revised:
07
11
2019
accepted:
15
11
2019
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
23
11
2019
Statut:
epublish
Résumé
Targeted drug delivery systems are commonly used to improve the therapeutic index of anti-cancer drugs by increasing their selectivity and reducing systemic distribution and toxicity. Ligand-conjugated nanoparticles (NPs) can be effectively applied for active chemotherapeutic targeting to overexpressed receptors of tumor cells. In this study, transferrin (T
Identifiants
pubmed: 31752417
pii: polym11111905
doi: 10.3390/polym11111905
pmc: PMC6918445
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : All India Council for Technical Education (AICTE), New Delhi, India,
ID : Research Promotion Scheme (RPS 2012-2013)
Organisme : Portuguese Foundation for Science and Technology (FCT/MEC)
ID : the project M-ERA-NET-0004/2015 (PAIRED), through national funds, and co-financed by FEDER, under the Partnership Agreement PT2020
Organisme : :
ID : Nutraceutica come supporto nutrizionale nel paziente oncologico, CUP: B83D18000140007
Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Biomater Appl. 2017 Apr;31(9):1247-1256
pubmed: 28350205
Int J Pharm. 2017 Jan 10;516(1-2):61-70
pubmed: 27825867
J Control Release. 2014 Sep 28;190:31-2
pubmed: 25356469
Small. 2018 Jan;14(2):
pubmed: 29154484
Eur J Cancer. 2017 Jul;79:152-157
pubmed: 28494406
J Control Release. 2019 May 10;301:62-75
pubmed: 30876953
J Control Release. 2009 May 21;136(1):21-9
pubmed: 19331851
Adv Drug Deliv Rev. 2013 Jan;65(1):80-8
pubmed: 23036224
Eur J Pharm Biopharm. 2015 Sep;95(Pt B):261-70
pubmed: 25681744
Pharmaceutics. 2019 Jul 24;11(8):null
pubmed: 31344882
Exp Cell Res. 2017 Apr 1;353(1):35-45
pubmed: 28267437
J Colloid Interface Sci. 2010 Oct 1;350(1):117-25
pubmed: 20598703
Molecules. 2019 Oct 28;24(21):null
pubmed: 31661906
J Control Release. 2017 Apr 28;252:73-82
pubmed: 28235591
Dig Liver Dis. 2017 May;49(5):552-556
pubmed: 28179095
Colloids Surf B Biointerfaces. 2009 Aug 1;72(1):48-56
pubmed: 19403277
Colloids Surf B Biointerfaces. 2016 Sep 1;145:241-250
pubmed: 27187188
Nanoscale Res Lett. 2009 Jan 16;4(4):287-295
pubmed: 20596545
Oncology. 2017;92(4):221-228
pubmed: 28110330
Acta Oncol. 2017 Jan;56(1):46-51
pubmed: 27911128
Rev Recent Clin Trials. 2017;12(3):216-222
pubmed: 28552047
Int J Pharm. 2016 Sep 25;511(2):719-27
pubmed: 27480398
Bioimpacts. 2017;7(1):49-57
pubmed: 28546953
Patient Prefer Adherence. 2018 Oct 05;12:1975-1987
pubmed: 30323567
Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
pubmed: 2946403
Acta Pharmacol Sin. 2017 Jun;38(6):943-953
pubmed: 28552909
Chem Biol Interact. 2015 May 25;233:81-94
pubmed: 25824412
Biochem Biophys Res Commun. 2017 May 27;487(2):255-261
pubmed: 28412359
Adv Healthc Mater. 2018 Aug;7(15):e1800106
pubmed: 29797508
Eur J Pharm Biopharm. 2009 Feb;71(2):190-5
pubmed: 18929649
Pharmaceutics. 2019 Sep 06;11(9):null
pubmed: 31500106
Adv Drug Deliv Rev. 2017 May 15;114:79-101
pubmed: 28545888
Biomed Rep. 2014 Jul;2(4):545-548
pubmed: 24944805
BMC Health Serv Res. 2016 Apr 29;16:163
pubmed: 27130440
J Am Chem Soc. 1971 May 5;93(9):2325-7
pubmed: 5553076
Colloids Surf B Biointerfaces. 2012 Apr 1;92:175-9
pubmed: 22221459
Eur J Pharm Sci. 2014 Oct 15;63:29-35
pubmed: 25010261
Adv Mater. 2017 Jun;29(24):
pubmed: 28397966
Colloids Surf B Biointerfaces. 2012 Jun 1;94:274-80
pubmed: 22377218
Biomaterials. 2017 Aug;137:23-36
pubmed: 28528300
Colloids Surf B Biointerfaces. 2017 Aug 1;156:19-28
pubmed: 28499201
BMC Womens Health. 2017 Sep 5;17(1):73
pubmed: 28870183
Methods Mol Biol. 2004;281:301-11
pubmed: 15220539
Oncotarget. 2017 Feb 28;8(9):14925-14940
pubmed: 28122339
Drug Deliv. 2017 Nov;24(1):10-19
pubmed: 28155336
J Nanobiotechnology. 2018 Mar 27;16(1):32
pubmed: 29587747
Int J Pharm. 2016 Mar 30;501(1-2):350-61
pubmed: 26844786
J Photochem Photobiol B. 2017 Jun;171:67-74
pubmed: 28478351
Mol Cancer Ther. 2017 Feb;16(2):323-333
pubmed: 27956521
J Aging Res. 2015;2015:682503
pubmed: 26346487